A Decade of Transition from Chemical to Green Synthesis of Nanoceria and Nanozirconia: Exploring Their Biomedical Potential

Abstract Nanotechnology has become a valuable tool in nanomedicine, providing new ways to combat various biomedical challenges. This study contrasts green synthesis methods, which use plant extracts, with traditional techniques like sol–gel and hydrothermal synthesis. While traditional methods produce well‐defined nanoparticles, they rely on toxic reagents and harsh conditions. Although green synthesis provides a sustainable substitute, it faces difficulties with standardization and reproducibility. Nanoceria and nanozirconia are commonly used in biomedicine due to their redox properties, biocompatibility, and ability to regulate reactive oxygen species (ROS) levels and oxidative stress. Nanozirconia (ZrO 2 nanoparticles) is recognized for its strength and stability, making it well‐suited for dental applications. Nanoceria (CeO 2 nanoparticles) is known for its redox activity and biocompatibility, particularly in tissue engineering. The review highlights that the antibacterial activity differs across the synthesis methods, with CeO 2 showing better efficacy than ZrO 2 due to its redox behavior and interactions with membranes. The cytotoxicity analysis emphasizes the need to refine synthesis parameters to lower dose‐related toxicity. Overall, the study highlights the role of green synthesis for producing biocompatible nanoparticles and encourages its broader use in environmentally friendly biomedical nanotechnology.